These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1231453)

  • 21. [Heparin and blood platelets].
    Komarnicki M; Kaźmierczak M
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):899-901. PubMed ID: 2487948
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolonged arterial occlusion caused by thrombus development at sites of arterial bifurcation.
    Araki H; Ishihara N
    Jpn Circ J; 1997 May; 61(5):413-20. PubMed ID: 9192241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spontaneous neonatal arterial thrombosis: a report of 4 neonates].
    Nouri-Merchaoui S; Mahdhaoui N; Trabelsi S; Seboui H
    Arch Pediatr; 2012 Apr; 19(4):413-8. PubMed ID: 22381668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of platelet prostaglandin cyclic endoperoxides in thrombosis.
    Lagarde M; Dechavanne M
    Lancet; 1977 Jan; 1(8002):88. PubMed ID: 63724
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparative study of heparin responses in arterial and venous thromboembolism using molecular markers for thrombosis.
    Sobel M; Sternbergh WC; Marques D; Grimsdale AS
    Circulation; 1993 Nov; 88(5 Pt 2):II426-31. PubMed ID: 8222189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis: studies under flow conditions.
    Badimon L; Badimon JJ; Turitto VT; Fuster V
    Ann N Y Acad Sci; 1987; 516():527-40. PubMed ID: 3439747
    [No Abstract]   [Full Text] [Related]  

  • 27. Arterial thrombosis and the vessel wall.
    Sixma JJ
    J R Coll Physicians Lond; 1976 Jan; 10(2):202-4. PubMed ID: 1246022
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibitory effects of activated protein C and heparin on thrombotic arterial occlusion in rat mesenteric arteries.
    Araki H; Nishi K; Ishihara N; Okajima K
    Thromb Res; 1991 May; 62(3):209-16. PubMed ID: 1891766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis prevention.
    Chan AK; Rak J; Berry L; Liao P; Vlasin M; Weitz J; Klement P
    Circulation; 2002 Jul; 106(2):261-5. PubMed ID: 12105168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions.
    Gowert NS; Krüger I; Klier M; Donner L; Kipkeew F; Gliem M; Bradshaw NJ; Lutz D; Köber S; Langer H; Jander S; Jurk K; Frotscher M; Korth C; Bock HH; Elvers M
    Cell Signal; 2017 Dec; 40():210-221. PubMed ID: 28943410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Medical treatment of retinal venous occlusions with a new defibrinating agent (Defibrase). Preliminary study].
    Gaudric A; Tolub O; Coscas G; Conard J; Samama M; Lelong F
    Bull Soc Ophtalmol Fr; 1982 Jan; 82(1):79-82. PubMed ID: 7049431
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanisms of platelet activation and development of antiplatelet agents].
    Cazenave JP; Gachet C; Lanza F
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
    Olsson P; Blombäck M; Egberg N; Ekeström S
    Thromb Res; 1976 Sep; 9(3):277-87. PubMed ID: 982350
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo.
    Metzig C; Grabowska E; Eckert K; Rehse K; Maurer HR
    In Vivo; 1999; 13(1):7-12. PubMed ID: 10218125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of MGDF on platelet function and thrombosis in animal models.
    Toombs CF
    Stem Cells; 1998; 16 Suppl 2():121-6. PubMed ID: 11012184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increased fibrinolytic activity by sequential treatment with defibrase-plasminogen-urokinase in pulmonary embolism and deep venous thrombosis].
    Brochier M; Griguer P; Raynaud P; Fauchier JP; Charbonnier B
    Arch Mal Coeur Vaiss; 1981 Jul; 74(7):761-9. PubMed ID: 6794497
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitory effect of activated protein C and heparin on arterial thrombosis].
    Araki H
    Nihon Rinsho; 1992 Feb; 50(2):408-12. PubMed ID: 1613999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of heparin in current therapy of thrombotic disease].
    Komarnicki M
    Pol Arch Med Wewn; 1982 Apr; 67(4):183-7. PubMed ID: 6752906
    [No Abstract]   [Full Text] [Related]  

  • 39. THE LIMITATIONS OF HEPARIN THERAPY AFTER ARTERIAL RECONSTRUCTION.
    SALZMAN EW
    Surgery; 1965 Jan; 57():131-8. PubMed ID: 14242040
    [No Abstract]   [Full Text] [Related]  

  • 40. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.